Clinical Trials
6 trialsNCT04673175 2026-01-21
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Weill Medical College of Cornell University
Phase 4 Terminated
NCT06075888 2024-06-24
ADNEMIA
Poitiers University Hospital
Phase NA Recruiting
NCT01321879 2019-12-27
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00398411 2015-06-29
MoxiProph
University of Cologne
Phase 3 Completed
NCT01820962 2013-03-29
Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients
Maastricht University Medical Center
Phase 3 Terminated
NCT00735813 2012-09-05
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
Aarhus University Hospital
Phase 3 Completed